Skip to content
DraconiticResearch
Search Sources API
197,693 studies31 sourcesUpdated 49 min ago
Peer-reviewedCC BYImmunity, inflammation and disease

JQ1 Inhibits the Hyperproliferation and Aggressiveness of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via Regulating IL7R.

  1. 1Department of Pharmacology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou, China.
  2. 2Department of Pharmacy, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Jinhua, China.

Abstract

Background

Rheumatoid arthritis (RA) is a chronic autoimmune bone disease. BRD4 is implicated in the pathogenesis of bone disorders. This study aimed to investigate the effects of a BRD4 inhibitor JQ1 on RA.Methods

Fibroblast-like synoviocytes (FLS) were exposed to TNF-α to establish an in vitro RA model. mRNA levels were detected using RT-qPCR. Protein expression was assessed by Western blot. The behaviors of FLS were analyzed using CCK-8, EdU, wound scratch, and transwell assays.Results

We found that LPS exposure promoted an inflammatory response in FLS, as well as mediated cell proliferation and migration. Interestingly, JQ1 inhibited the inflammatory response and the morbidity of FLS. Mechanistically, targeting BRD4 by JQ1 inhibited acetylation modification for H3K27 on IL7R promoter, downregulating the expression of IL7R. However, IL7R overexpression reversed the effects of JQ1 and promoted the inflammatory response and the morbidity of FLS.Conclusion

JQ1 inhibits the inflammatory response, proliferation, and migration of RA FLS via downregulating IL7R. Therefore, JQ1 exerts protective effects on RA.

Related

  1. Targeting the NLRP3 inflammasome in rheumatoid arthritis fibroblast-like synoviocytes: pathogenic mechanisms, therapeutic strategies, and translational perspectives
    Lunmin Bao, Haibing Dai, Daoming Wang +1
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  2. Sanguinarine ameliorates rheumatoid arthritis by activating the Hippo-YAP/TAZ pathway to induce apoptosis and suppress inflammation in fibroblast-like synoviocytes
    Jun Cai, Yong-Gu Cai, Jing-Yi Luo +3
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  3. Microenvironment-Triggered Sequentially Targeted Micelles for Dual Regulation of Macrophages and Fibroblast-Like Synoviocytes via ROS-Responsive Rg1 Release and HAP-1-Mediated Celastrol Delivery in Rheumatoid Arthritis Therapy.
    Yani Zhang, Ruibo Guo, Ying Zheng +7
    International journal of nanomedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
  4. Fibroblast-like synoviocytes exacerbate autoimmune arthritis upon psychological stress in an IL-6–dependent manner
    Jun Tamura, Shigeru Tanaka, Keishi Etori +12
    Science AdvancesPeer-reviewedCC BYFull textGeneral medicineCrossrefEurope PMC
  5. Progesterone Modulates Protein Synthesis in Osteoarthritic Fibroblast-like Synoviocytes
    Fadi Askar, Georgios Chatziagorou, Sofia Wüstenhagen +6
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
BibTeX
@article{hong2026inhibits,
  title = {{JQ1 Inhibits the Hyperproliferation and Aggressiveness of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via Regulating IL7R.}},
  author = {Lin Hong and Tingting Chen and Yuchen Jiang and Xiaohua Zhang},
  journal = {Immunity, inflammation and disease},
  year = {2026},
  month = oct,
  doi = {10.1002/iid3.70540},
  url = {https://europepmc.org/article/MED/42949421},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - JQ1 Inhibits the Hyperproliferation and Aggressiveness of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via Regulating IL7R.
AU  - Lin Hong
AU  - Tingting Chen
AU  - Yuchen Jiang
AU  - Xiaohua Zhang
PY  - 2026
DA  - 2026/10/01
JO  - Immunity, inflammation and disease
DO  - 10.1002/iid3.70540
UR  - https://europepmc.org/article/MED/42949421
AB  - Background  Rheumatoid arthritis (RA) is a chronic autoimmune bone disease. BRD4 is implicated in the pathogenesis of bone disorders. This study aimed to investigate the effects of a BRD4 inhibitor JQ1 on RA.Methods  Fibroblast-like synoviocytes (FLS) were exposed to TNF-α to establish an in vitro RA model. mRNA levels were detected using RT-qPCR. Protein expression was assessed by Western blot. The behaviors of FLS were analyzed using CCK-8, EdU, wound scratch, and transwell assays.Results  We found that LPS exposure promoted an inflammatory response in FLS, as well as mediated cell proliferation and migration. Interestingly, JQ1 inhibited the inflammatory response and the morbidity of FLS. Mechanistically, targeting BRD4 by JQ1 inhibited acetylation modification for H3K27 on IL7R promoter, downregulating the expression of IL7R. However, IL7R overexpression reversed the effects of JQ1 and promoted the inflammatory response and the morbidity of FLS.Conclusion  JQ1 inhibits the inflammatory response, proliferation, and migration of RA FLS via downregulating IL7R. Therefore, JQ1 exerts protective effects on RA.
SN  - 2050-4527
ER  -